Separate queen body parts and tissues, as well as whole worker bees from the inoculation assays were homogenized using a micro-pestle in a 1.5 mL centrifuge tube, followed by a total RNA extraction with an established
TRIzol™ (Invitrogen, Carlsbad, CA, USA) protocol [61 (
link)]. The concentration and purity of the extracted RNA samples were measured using a
Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA), and total RNA concentration was adjusted to 20 ng/µL in
molecular grade water (Fisher Scientific, Fair Lawn, NJ, USA). Thereafter, cDNA was synthesized for each sample using the
High-Capacity cDNA Reverse-Transcription Kit (Applied Biosystems, Foster City, CA, USA). Ten microliters of the RNA template (20 ng/µL) were added to 10 µL of the provided cDNA master mix, followed by an incubation period as recommended by the manufacturer: 10 min at 25 °C, 120 min at 37 °C, and 5 min at 85 °C. The resulting cDNA solution was then diluted 10-fold in
molecular grade water and stored at −80 °C to serve as the template in subsequent qPCR-based analysis of immune gene expression and virus quantification.
Bhatia S., Baral S.S., Vega Melendez C., Amiri E, & Rueppell O. (2021). Comparing Survival of Israeli Acute Paralysis Virus Infection among Stocks of U.S. Honey Bees. Insects, 12(1), 60.